Home » Newsletters » BioWorld Science

BioWorld Science

March 1, 2022

View Archived Issues

S100A4 levels correlate with active eosinophilic esophagitis

IL13RA1 is a therapeutic target in the treatment of EoE

New complement factor B inhibitors identified at Shanghai Meiyue Biotech Development

PROTACs targeting IRAK-4 synthesized at Shanghai Leadingtac Pharmaceutical

Kira Pharmaceuticals discovers C5aR antagonists

BeiGene divulges new G12C mutant GTPase KRAS inhibitors

Beijing Tide Pharmaceutical patents son of sevenless homolog 1 inhibitors

Fibulin-2 as a novel therapeutic target in multiple sclerosis

Study finds potential entry points to Huntington's therapy

Targeting MRGPRX2-mediated mast cell activation as a therapeutic strategy for atopic dermatitis

Discovery of novel orally bioavailable inhibitors of EGFR T790M/C797S mutants

ANGPTL4 is elevated in peanut allergy

Tonix enters research agreement with Inserm to study oxytocin in Prader-Willi syndrome mouse model

PBI-0451 shows promising results for the treatment of COVID-19

SpFN_1B-06-PL vaccine induces durable immune response against pathogens

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...